What NM PHARMA does

NM Pharma (NMPharma Malta) is a privately held Maltese pharmaceutical company that imports, distributes, wholesales, and exports prescription medications, OTC products, food supplements, controlled substances, vaccines, and medical devices. The company serves three customer segments: (i) the private healthcare market in Malta and Gozo through a field sales team covering 229 pharmacies (including 6 in-house pharmacies), 5 private hospitals, 15 private clinics, and 25 dental clinics; (ii) Malta's National Health Service via tenders and urgent calls issued by the Central Procurement & Supplies Unit; and (iii) international export customers across the UK, Netherlands, France, Ireland, Italy, Spain, Romania, Greece, North Africa, and Asia, which the company identifies as its fastest-growing segment.

Operations are anchored by a 1,500 sqm centralized distribution centre in Malta with capacity for over 500 pallets, EU Goods Distribution Practice (GDP) compliance, precise temperature control, and a dedicated cold room for cold-chain products. The company holds an in-house Good Manufacturing Practice (GMP) license from the Malta Medicines Authority for pharmaceutical relabeling across two production lines, enabling over-labeling, primary labeling, and package insert replacement. This license gives the company procurement flexibility across EU member states. NM Pharma also owns six consumer brands (Hydratis, Linea Act, Medi Drink Neo, Mio Magnesio, Quies, Zymerex) distributed via an e-commerce storefront with home delivery and warehouse collection options across Malta and Gozo.

The revenue model is transaction-based across all four streams: private-market distribution, NHS tenders, export sales, and direct-to-consumer e-commerce. Pricing on the consumer channel ranges from approximately €3.75 to €74.99 per unit, with free delivery over €30 and a 5% warehouse-collection discount. Marketing is primarily digital via the corporate website, Facebook, and Instagram. No revenue, headcount, ownership, or funding data is publicly disclosed.

Name

NM PHARMA

Legal name

NMPharma Malta

Website

https://nmpharma.com.mt

Company type

Private

Operating status

Operating

Short description

NM Pharma is a privately held Maltese pharmaceutical importer, distributor, wholesaler, and exporter serving 229 Maltese pharmacies, hospitals, clinics, and dental practices, plus Malta's NHS tenders and international customers across Europe, North Africa, and Asia from a GMP-licensed centralized facility.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

akta.pro secondary industries

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical distribution
• Pharmaceutical import export
• Healthcare product wholesale
• Medical device distribution
• Pharmaceutical relabeling services

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Distribution: Distribution of prescription medications, OTC products, food supplements, controlled substances, vaccines, and medical devices to pharmacies, hospitals, clinics, and dental practices throughout Malta and Gozo
2. Government Healthcare Contracts: Participation in government tenders issued by Malta's NHS Central Procurement & Supplies Unit for acquisition of pharmaceuticals and medical equipment
3. Export: Export of pharmaceuticals including low-cost generics to high-end vaccines, serving customers in UK, Netherlands, France, Ireland, Italy, Spain, Romania, Greece, North Africa, Asia, and other EU countries. Fastest-growing business segment.
4. Direct-to-Consumer E-commerce: Online retail sales of food supplements and health products to individual consumers via company e-commerce platform

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

NM Pharma distributes, wholesales, and exports pharmaceuticals, medical devices, and related healthcare products from its centralized distribution centre in Malta, holding a GMP license for in-house pharmaceutical relabeling. The company serves private healthcare providers (pharmacies, hospitals, clinics, dental practices), Malta's National Health Service through government tenders, and international export customers across Europe, North Africa, and Asia. It also retails a portfolio of six proprietary health supplement and wellness brands (Hydratis, Linea Act, Medi Drink Neo, Mio Magnesio, Quies, Zymerex) through its own e-commerce platform.

Product overview

NM Pharma is a Maltese pharmaceutical import, export, and distribution company operating from a centralized distribution centre. The company offers a diverse portfolio of pharmaceutical and health products across six main brands: Hydratis (hydration supplements), Linea Act (comprehensive food supplements including vitamins, minerals, probiotics, sleep aids, respiratory care, and weight management), Medi Drink Neo (medical nutritional drinks), Mio Magnesio (various magnesium formulations), Quies (ear care products including earplugs and ear hygiene), and Zymerex (digestive health supplements). The company also provides regulatory services including pharmaceutical relabeling under GMP license from Malta Medicines Authority, serves the National Health Service through tender participation, and exports throughout Europe and beyond.

Differentiator

Problem solved

Functional benefit

Brands

• Hydratis: Brand of pharmaceutical/health products
• Linea Act
• Medi Drink Neo
• Mio Magnesio
• Quies
• Zymerex

Products and services

• Hydratis A proprietary brand of hydration and wellness food supplements distributed by NM Pharma via its e-commerce platform.
• Linea Act
• Medi Drink Neo
• Mio Magnesio
• Quies
• Zymerex
• Pharmaceutical Distribution to Private Healthcare Providers
• NHS Malta Government Tender Supply
• International Pharmaceutical Export
• GMP-Licensed Pharmaceutical Relabeling

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Mawdsleys: Mawdsleys is a UK-based specialist pharmaceutical distributor focused on cross-border supply, including controlled substances and products for export markets. It is comparable to NM Pharma as a mid-sized UK-rooted exporter with strong supplier networks into Europe, Africa, and Asia, mirroring NM Pharma's export-sourcing business model.
• Mediq: Mediq is a European healthcare distributor and solutions provider focused on medical devices, pharmaceuticals, and home care supplies across multiple EU markets. It is a relevant comparable as a multi-country European pharma/medical device distributor with cross-border logistics, similar to NM Pharma's diversified portfolio across Rx, OTC, supplements, and devices.
• Oriola Corporation: Oriola is a Finnish-listed pharmaceutical distributor and retail pharmacy operator serving pharmacies, hospitals, and healthcare providers in the Nordics and Baltics, with comparable wholesale-plus-brands-plus-pharmacy mix. It is relevant as a similarly structured mid-sized European pharma distributor operating across multiple countries, analogous to NM Pharma's domestic-plus-export positioning.
• Tamro (PHOENIX Group subsidiary): Tamro is a Nordic pharmaceutical distributor (now part of PHOENIX Group) that supplies pharmacies, hospitals, and healthcare providers across Finland, the Baltics, and broader Europe. It is a relevant peer given similar role as regional pharma distributor with growth ambitions outside its home market, mirroring NM Pharma's Malta-centric but export-ambitious model.

Broad incumbents

• PHOENIX Group: PHOENIX Group is one of the largest pharmaceutical distribution groups in Europe, with operations across wholesale, retail pharmacy (including the Benavente, Lloyds partnerships), and pharma pre-wholesale. It is comparable as a continent-wide pharma wholesaler that competes with NM Pharma on cross-border sourcing for export customers and targets similar pharmacy and hospital end markets.
• McKesson Europe (formerly LloydsPharmacy Distribution): McKesson Europe operates pharmaceutical wholesale and retail pharmacy businesses across multiple European countries, sourcing and distributing prescription, OTC, and specialty products. It competes with NM Pharma in cross-border EU pharmaceutical supply and offers overlapping service lines including GDP-compliant warehousing and supplier-network intermediation.
• Cencora (formerly AmerisourceBergen): Cencora is a global pharmaceutical solutions company providing distribution, consulting, and specialty services across human and animal health markets. It is a broad incumbent peer that competes with mid-sized distributors like NM Pharma, particularly on specialty pharmaceuticals, vaccines, and international sourcing for emerging markets.
• Alliance Healthcare: Alliance Healthcare is a leading European pharmaceutical wholesaler serving pharmacies, hospitals, and clinics across multiple EU countries, with distribution, pre-wholesale, and healthcare services. It is comparable to NM Pharma as a wide-portfolio EU pharma distributor, though considerably larger in scale and geographic reach than NM Pharma's Maltese footprint.

Emerging players

• European Pharma Group (EPG) / Surgipharm-style independent distributors: Surgipharm is an independent pharmaceutical distributor operating in frontier and emerging markets with cross-border sourcing from European suppliers. It is comparable to NM Pharma as a smaller pharma importer-distributor that competes in similar cross-border supply chains into Africa and other emerging regions where NM Pharma is expanding.
• Smartway Pharma India (cross-border distribution example): Smartway Pharma operates cross-border pharmaceutical distribution between regulated and emerging markets, leveraging supplier networks in Europe. It is comparable to NM Pharma as a mid-sized distributor spanning Europe-to-Asia and Europe-to-Africa flows, with a similar sourcing-and-reselling model into markets with complex regulatory requirements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/nmpharmamt
• Instagraminstagram.com/nm_pharma
• LinkedInlinkedin.com/company/nm-pharma-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NM PHARMA